About
Technology
Issues
FAQ
Links
Official Page
Ruxolitinib: a potent and selective Janus kinase 1 and 2 inhibitor in patients with myelofibrosis. An update for clinicians
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.